Your browser is no longer supported. Please, upgrade your browser.
JNJ Johnson & Johnson daily Stock Chart
Johnson & Johnson
IndexDJIA S&P500 P/E22.18 EPS (ttm)5.37 Insider Own0.02% Shs Outstand2.75B Perf Week-0.73%
Market Cap326.81B Forward P/E16.74 EPS next Y7.11 Insider Trans-10.92% Shs Float2.74B Perf Month-3.72%
Income15.03B PEG3.40 EPS next Q1.66 Inst Own67.30% Short Float0.85% Perf Quarter5.99%
Sales70.88B P/S4.61 EPS this Y-3.90% Inst Trans-0.15% Short Ratio3.41 Perf Half Y14.71%
Book/sh26.40 P/B4.51 EPS next Y6.32% ROA14.20% Target Price126.72 Perf Year27.27%
Cash/sh15.51 P/C7.67 EPS next 5Y6.52% ROE26.80% 52W Range87.39 - 125.23 Perf YTD18.35%
Dividend3.20 P/FCF109.52 EPS past 5Y2.80% ROI16.90% 52W High-4.95% Beta0.62
Dividend %2.69% Quick Ratio2.70 Sales past 5Y2.60% Gross Margin69.60% 52W Low36.22% ATR1.00
Employees127100 Current Ratio3.10 Sales Q/Q3.90% Oper. Margin33.00% RSI (14)37.45 Volatility0.83% 0.83%
OptionableYes Debt/Eq0.36 EPS Q/Q-10.90% Profit Margin27.30% Rel Volume0.95 Prev Close118.57
ShortableYes LT Debt/Eq0.34 EarningsJul 19 BMO Payout54.20% Avg Volume6.81M Price119.04
Recom2.40 SMA20-2.15% SMA50-1.59% SMA2009.34% Volume6,482,345 Change0.40%
Jul-21-16Reiterated Deutsche Bank Hold $125 → $142
Jul-20-16Reiterated UBS Buy $126 → $137
Jul-20-16Reiterated RBC Capital Mkts Outperform $125 → $133
May-20-16Initiated Standpoint Research Sell $94
Apr-20-16Reiterated RBC Capital Mkts Outperform $122 → $125
Apr-20-16Reiterated Piper Jaffray Neutral $105 → $106
Apr-15-16Reiterated RBC Capital Mkts Outperform $114 → $122
Mar-14-16Upgrade Goldman Sell → Neutral
Dec-01-15Upgrade Barclays Equal Weight → Overweight $101 → $115
Oct-05-15Resumed Piper Jaffray Neutral $105
May-21-15Reiterated Deutsche Bank Hold $106 → $110
Dec-08-14Reiterated RBC Capital Mkts Outperform $110 → $114
Jul-16-14Reiterated Deutsche Bank Hold $102 → $107
Apr-17-14Reiterated Argus Buy $104 → $116
Apr-16-14Reiterated RBC Capital Mkts Outperform $104 → $106
Jan-10-14Downgrade Barclays Overweight → Equal Weight $99
Jan-07-14Upgrade RBC Capital Mkts Sector Perform → Outperform $88 → $104
Dec-16-13Reiterated Deutsche Bank Hold $93 → $95
Jul-18-13Reiterated Argus Buy $96 → $104
Jul-17-13Reiterated Barclays Overweight $95 → $99
Aug-26-16 09:00PM  Beat Up on the Corporations This Election Year; Market Helping Consumer: Jim Cramer's Best Blogs
02:00PM  5 Stocks With Rising Dividends for 50 Years in a Row at Kiplinger
11:10AM  7 Healthcare Dividend Stocks for Quality and Security at Kiplinger
10:48AM  After Jackson Hole - The Four Most Important Investment Issues at Forbes
Aug-25-16 12:17PM  7 Stocks to Buy for the Baby Boomer Retirement Wave
10:00AM  Johnson & Johnson to Participate in the 2016 Wells Fargo 11th Annual Healthcare Conference PR Newswire
Aug-24-16 04:53PM  Merck Offers Value and Steady Dividend Growth
11:50AM  How MAKO Robots Could Contribute to SYKs Orthopedics Growth
11:04AM  How Did Bristol-Myers Squibb Fare in 2Q16?
11:01AM  10 Stocks Billionaire John Paulson Is Buying for 2016
10:04AM  How Humira-Related Uncertainty Has Affected AbbVies Valuations
10:00AM  Write A Prescription For More Pharma M&A With This ETF
09:10AM  J&J (JNJ) Seeks EU Approval for Darzalex's Expanded Use
12:30AM  [$$] MPs call for ban on microbeads in toiletries at Financial Times
Aug-23-16 02:31PM  Why Richard Bernstein Says Its Not the End of the World
11:11AM  Top 6 Pharmaceutical Companies Globally at Investopedia
Aug-22-16 07:36PM  U.S. Stocks Trading Lower with Market Uncertainty
04:57PM  S&P 500, Dow industrials book a loss as oil snaps win streak at MarketWatch
04:01PM  Apple, J&J Weigh on DJIA Monday at 24/7 Wall St.
09:07AM  McDonald's, Verizon And 3 Others That May Drag Down The Dow at Forbes
08:22AM  Johnson & Johnson Could Become the First Company to Reach a $1 Trillion Valuation at Motley Fool
12:35AM  [$$] Two Strategies, One Crowded Trade at The Wall Street Journal
Aug-21-16 07:04PM  3 Stocks on the Rise You Can Buy Today at Motley Fool
06:45AM  Here's the Best Dividend Stock in Big Pharma at Motley Fool
Aug-19-16 05:04PM  How Does Bristol-Myers Squibbs Valuation Compare to Peers?
04:19PM  Hunting For Biotech Stocks? Understand The Earnings Formula First
12:28PM  Geron Shares Seen Range-Bound On Lack Of Major Data Until Late 2017
11:04AM  What Happened to Sanofis Consumer Healthcare and Generics Franchise in 2Q16?
07:00AM  Quality at a Low Cost at Morningstar
07:00AM  No Pain, Potential for Lots of Gain at Morningstar
Aug-18-16 06:33PM  ETFs with exposure to Johnson & Johnson : August 18, 2016
03:51PM  Pursche: A disconnect between fundamentals and valuations
02:53PM  Deutsche Takes A Look At Johnson & Johnson's Patent Woes
02:26PM  Recent Patent Ruling A Positive For Pfizer
11:18AM  Why I Hate Johnson & Johnson Right Now (But I'll Never Sell) at Motley Fool
11:06AM  Why Portola Pharmaceuticals Inc Is Plunging Today at Motley Fool
10:58AM  These 10 Safe Dividend Stocks for Retirees Can Beat a Bear Market
07:55AM  Court rules Remicade patent is invalid at
07:39AM  J&J (JNJ) Remicade Patent Invalid, Pfizer to Launch Inflectra?
06:45AM  Greater Cincinnati firm faces lawsuit over deceptive marketing allegations at
Aug-17-16 07:16PM  Patent for J&J's Remicade invalidated, cheaper version looms
06:45PM  US Stocks Higher after July FOMC Minutes
06:10PM  [$$] Court Says Pfizer's Biosimilar of J&J's Remicade Doesn't Infringe Patent at The Wall Street Journal
04:06PM  J&J says court finds Remicade patent invalid Reuters
03:24PM  Gilead Sciences: Still Dominating Hepatitis C But at
01:54PM  Johnson & Johnson Announces Ruling Related to REMICADE┬« in the District of Massachusetts Federal Court Hearing PR Newswire
12:06PM  Jim Cramer -- Will Interest Rates Rise? Check These 3 Stocks
11:04AM  CELGs Otezla Continues Dominating US Inflammation and Immunology
08:18AM  Johnson & Johnson breached its 50 day moving average in a Bearish Manner : JNJ-US : August 17, 2016
08:09AM  Cramer: 3 Stocks Say Interest Rates Are Going Higher
06:50AM  J&J's (JNJ) Depression Treatment Esketamine Gets BTD
Aug-16-16 07:22PM  U.S. Market Indexes Lower on Tuesday
06:48PM  Novartis Needs to Stem the Bleeding From Gleevec Decline
05:35PM  Why a hedge fund wants this East Bay drug company to run like Olive Garden at
04:26PM  Stocks Fall, Oil Rises; Dick's Sporting Goods A Bright Spot
04:20PM  Stocks close lower amid hawkish Fed talk at MarketWatch
03:45PM  Kentucky AG sues Johnson & Johnson over vaginal implants
12:29PM  According to Janus, These Sectors Are Immune to Rising Inflation
11:04AM  Remicade Is Driving Down Mercks Immunology Franchise
09:00AM  Esketamine Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Major Depressive Disorder with Imminent Risk for Suicide PR Newswire
09:00AM  7 Safe Dividend Stocks Paying You More Each Year
Aug-15-16 06:37PM  Paulson Shifts Health-Care Stakes, Adds FedEx at The Wall Street Journal
02:31PM  How this stock fund routinely beats the S&P 500 at MarketWatch
10:38AM  Inovio Expands Enrollment in Ebola Vaccine Phase I Study
09:56AM  Tampa office park sold for $73 million at
09:30AM  Jobs at these 10 companies will literally pay you for life
Aug-12-16 05:39PM  Zimmer Biomet Gains Strong Top-Line Momentum
05:38PM  Zimmer Biomets Realized Synergies, Market Position after Integration
02:06PM  These 2 Publicly Traded Companies Have Better Credit Ratings Than the U.S. Government at Motley Fool
Aug-11-16 03:44PM  Johnson & Johnson: Still a Steady Dividend Payout
01:04PM  JOHNSON & JOHNSON Financials
11:04AM  Why Did AGCO Increase Its Fiscal 2016 Sales Guidance?
Aug-10-16 12:54PM  Gilead Sciences: Going, Going at
Aug-09-16 10:28PM  Why Is Pfizers Valuation Low Compared to Its Peers?
Aug-08-16 04:59PM  Canada's Plan To Fight Opioid Addiction Might Hurt Its Weakest Patients
07:30AM  The newest workplace benefit for millennials: Paying down their student loans
07:00AM  July Ratings Activity Features Downgrades and New Ratings at Morningstar
Aug-05-16 02:50PM  Bristol-Myers Tanks, Buy These Two Large Cap Pharma Stocks Instead
02:22PM  New Research Reports for Tesla, Exxon, JNJ & Others
12:34PM  Yacktman Funds Comments on Johnson & Johnson
12:20PM  Yacktman Focused Fund 2nd Quarter Commentary
10:39AM  Another Jobs Report Bonanza: Big July Job Gains Lend Support To Stock Market
Aug-04-16 07:37PM  [$$] Funding Snapshot: Torax Raises $25M for Medical Devices at The Wall Street Journal
04:13PM  JOHNSON & JOHNSON Files SEC form 10-Q, Quarterly Report
12:15PM  Apples 5 Largest Shareholders at 24/7 Wall St.
10:04AM  Geron (GERN) Posts Narrower-Than-Expected Loss in Q2
Aug-03-16 04:04PM  Johnson & Johnson: The Ultimate Buy, Hold Dividend Stock
12:22PM  Pharma ETFs Soaring on Solid Q2 Earnings
Aug-02-16 04:19PM  Meet The Dow Industrials' 5 Standout Stocks This Year
03:00PM  3 big deals in Tampa Bay that slipped under the M&A radar at
02:13PM  Medical benefits of dental floss unproven
01:13PM  Lucas Capital Management Reveals Top Picks for Q3; Apple Inc. (AAPL) and Johnson & Johnson (JNJ) Among Them at Insider Monkey
10:18AM  [$$] Comings & Goings at The Wall Street Journal
08:22AM  Opko Health's Many Acquisitions Add Up to Varied Product Offerings and Potential Growth
Aug-01-16 04:58PM  Veeva Helps The Medicine Go Down Faster for Drug Giants
02:13PM  Momentum in Equities Could Slow
01:08PM  Tweedy Browne 2nd Quarter Shareholder Letter
11:08AM  Sales from This Amgen Product Helped the Companys Q2 Earnings
10:32AM  What to Expect from Pfizers 2Q16 Earnings
10:04AM  GlaxoSmithKlines Revenue Trend in 2Q16
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates through three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand name; oral care products under the LISTERINE brand name; skin care products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, LUBRIDERM, NEUTROGENA, and RoC brand names; women's health products, such as sanitary pads under the STAYFREE and CAREFREE, and o.b. tampon brand names; wound care products, including adhesive bandages under the BAND-AID brand name and first aid products under the NEOSPORIN brand name. This segment also provides over-the-counter medicines, including acetaminophen products under the TYLENOL brand name; cold, flu, and allergy products under the SUDAFED brand name; allergy products under the BENADRYL and ZYRTEC brand names; ibuprofen products under the MOTRIN IB brand name; and heartburn products under the PEPCID brand name. The Pharmaceutical segment provides various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment offers orthopaedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company offers its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JOHNSON & JOHNSON10% OwnerAug 16Buy12.00583,3336,999,9962,449,183Aug 18 05:11 PM
Caruso Dominic JExec VP, Finance; CFOJul 26Option Exercise65.6241,1462,700,001157,819Jul 28 04:34 PM
Caruso Dominic JExec VP, Finance; CFOJul 26Sale125.0141,1465,143,810116,673Jul 28 04:34 PM
Kapusta Ronald AController, CAOJul 22Sale125.012,935366,89625,725Jul 25 03:18 PM
Kapusta Ronald AController, CAOJul 21Option Exercise58.332,935171,19928,660Jul 25 03:18 PM
Kapusta Ronald AController, CAOJun 07Option Exercise58.333,000174,99028,725Jun 09 04:11 PM
Pruden Gary JExec VP, WW Chair, Med DevicesJun 07Sale116.039,7351,129,55243,630Jun 09 04:12 PM
Kapusta Ronald AController, CAOJun 07Sale115.793,000347,38125,725Jun 09 04:11 PM
Kapusta Ronald AController, CAOMay 10Option Exercise58.333,957230,81229,682May 12 05:09 PM
Kapusta Ronald AController, CAOMay 10Sale114.773,957454,15725,725May 12 05:09 PM
Caruso Dominic JVP, Finance; CFOFeb 08Option Exercise0.0029,0050125,466Feb 10 06:02 PM
Gorsky AlexChairman, CEOFeb 08Option Exercise0.0067,9330197,441Feb 10 06:02 PM
PETERSON SANDRA EGroup Worldwide ChairmanFeb 08Option Exercise0.007,633037,943Feb 10 06:03 PM
Fasolo PeterVP, Global Human ResourcesFeb 08Option Exercise0.0018,777056,512Feb 10 06:03 PM
Ullmann Michael HVP, General CounselFeb 08Option Exercise0.0016,697098,071Feb 10 06:03 PM
Stoffels PaulusChief Scientific OfficerFeb 08Option Exercise0.0028,2420131,104Feb 10 06:03 PM
Kapusta Ronald AController, CAOFeb 08Option Exercise0.002,598026,023Feb 10 06:03 PM
Fasolo PeterVP, Global Human ResourcesFeb 03Option Exercise72.54144,56810,486,963182,303Feb 04 06:04 PM
Fasolo PeterVP, Global Human ResourcesFeb 03Sale104.12144,56815,052,42037,735Feb 04 06:04 PM
Fasolo PeterVP, Global Human ResourcesFeb 02Option Exercise72.546,817494,50544,552Feb 04 06:04 PM
Fasolo PeterVP, Global Human ResourcesFeb 02Sale104.096,817709,58837,735Feb 04 06:04 PM
Caruso Dominic JVP, Finance; CFOJan 15Option Exercise0.0011,6020100,336Jan 20 07:25 PM
Fasolo PeterVP, Global Human ResourcesJan 15Option Exercise0.007,511040,578Jan 20 07:25 PM
Gorsky AlexChairman, CEOJan 15Option Exercise0.0027,1730140,534Jan 20 07:25 PM
PETERSON SANDRA EGroup Worldwide ChairmanJan 15Option Exercise0.003,053031,616Jan 20 07:25 PM
Ullmann Michael HVP, General CounselJan 15Option Exercise0.006,679083,907Jan 20 07:25 PM
Kapusta Ronald AController, CAOJan 15Option Exercise0.003,896024,699Jan 20 07:25 PM
Stoffels PaulusChief Scientific OfficerJan 15Option Exercise0.0011,2970106,585Jan 20 07:25 PM
PETERSON SANDRA EGroup Worldwide ChairmanDec 17Option Exercise0.0021,688040,730Dec 21 05:09 PM
Ullmann Michael HVP, General CounselNov 20Option Exercise58.3422,6261,320,00194,878Nov 24 01:00 PM
Ullmann Michael HVP, General CounselNov 20Sale102.4717,6501,808,54377,228Nov 24 01:00 PM
Caruso Dominic JVP, Finance; CFONov 02Option Exercise58.3420,5691,199,995109,303Nov 04 05:05 PM
Caruso Dominic JVP, Finance; CFONov 02Sale102.2120,5692,102,42388,734Nov 04 05:05 PM
Kapusta Ronald AController, CAOOct 23Option Exercise58.346,239363,98327,042Oct 27 03:38 PM
Kapusta Ronald AController, CAOOct 23Sale99.686,239621,90420,803Oct 27 03:38 PM